HEALTH

Dignified Products introduces magnifier to help with compliance

BY Michael Johnsen

TEMPE, Ariz. Dignified Products recently introduced its Pill Bottle Magnifier, an item that helps those who have difficulty with vision better read their prescription drug labels.

“Medicine compliance is complicated by the inability to read the prescription label,” the company stated. “Many people take the wrong prescription or the wrong dosage.” 

Presbyopia, an eye’s diminished ability to focus that’s associated with old age, begins impacting people around the age of 40. According to a 2006 AARP survey, 84 percent of adults 45 and older take at least one prescription or non-prescription drug

The item has been placed nationally at Wal-Mart stores at a price point of $2.97, the company reported.  

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Mann joins Nutrition 21 board

BY Michael Johnsen

PURCHASE, N.Y. Nutrition 21 on Wednesday announced that Peter Mann has joined its board effective Oct. 15.

Mann is a senior consumer and pharmaceutical products business executive with more than 35 years of general management, marketing and sales experience. In 2001, Mann was one of the founders and served as the chief executive officer of MedTech Holdings, which subsequently became Prestige Brands. Mann retired as chairman and chief executive officer of Prestige Brands Holdings in January.

“We are delighted that an industry leader of Peter Mann’s caliber has agreed to join our board,” stated Paul Intlekofer, Nutrition 21 president and chief executive officer. “In addition to being one of the most effective executives in the consumer products industry, he is a visionary who has created markets for many of the brands that we use on a regular basis to improve the quality of our lives. His broad industry experience and expertise will be instrumental to Nutrition 21 as we continue to progress on our strategic plan.”

Mann is a graduate of Brown University. He is currently a member of the Consumer Healthcare Products Association Board of Directors.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Hyland’s holds press conference on homeopathic remedies

BY Michael Johnsen

LOS ANGELES One day before the Food and Drug Administration meets to examine the safety and effectiveness of over-the-counter cough and cold medicines for infants and young children, Hyland’s Wednesday morning hosted a media conference call to highlight homeopathy remedies as a potential alternative to conventional OTC medicines.

Iris Bell, professor of family and community medicine, psychiatry and psychology at the College of Public Health of the University of Arizona College, noted there were several advantages to homeopathic remedies, including “low cost and an excellent safety record over its lengthy history,” she said. “Many people tend to confuse homeopathy as an alternative” to conventional medicine with the full gamut of alternative remedies, including herbal remedies. “In the United States, homeopathic [remedies] are regulated by the FDA” as drugs, Bell said.

Homeopathic remedies are safe and effective, even for children under the age of two, commented Timothy Fior, vice president of the Illinois Homeopathic Medical Association. “Homeopathy is very conducive to self-care,” he said, noting that there aren’t the same overdosing safety concerns with homeopathic remedies as there potentially are with synthetic medicines.

“The voluntary withdrawal of household names in children’s cold relief may cause many parents to believe that their children will have no alternatives in the alleviation of cold symptoms,” Hyland’s stated. “On the contrary, safe, all-natural options exist in the form of homeopathic medicines.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?